|
From
•>>January 2006
Roger Nicoll answers
a few questions about this month's fast moving front in the
field of Neuroscience & Behavior.
Field: Neuroscience & Behavior
Article: Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms
Authors: Chen, L;Chetkovich, DM;Petralia, RS;Sweeney, NT;Kawasaki, Y;Wenthold,
RJ;Bredt,
DS;Nicoll, RA
Journal: NATURE, 408 (6815): 936-943, DEC 21 2000
Addresses:
Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.
Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.
Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.
Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.
NIDCD, Neurochem Lab, NIH, Bethesda, MD 20892 USA.
|
|
Why do you think your
paper is highly cited?
|

“...the discovery of stargazin has opened a new chapter in the molecular regulation of AMPA receptors and by implication, learning and memory.”
|
|
The manuscript describes the role of a novel protein, termed
stargazin, in the trafficking of the AMPA subtype of glutamate
receptor in the brain. The paper shows the critical role of
stargazin in delivering AMPA receptors to the membrane surface and
then, by a separate mechanism, targeting these surface receptors
to the synapse. It is generally accepted that the trafficking of
AMPA receptors underlies certain forms of synaptic plasticity
involved in learning and memory, and thus our findings have
generated a great deal of excitement regarding the molecular
mechanisms of memory.
Does it describe a new discovery or a new methodology that’s
useful to others?
As a result of our discovery, many laboratories, including my
own, have pursued numerous leads. For instance, my colleague, David
Bredt, and I have found that stargazin is a member of a
family of proteins that have similar, but not identical, functions
throughout the brain. Furthermore, in addition to their role in
trafficking, we, and others, have recently discovered that these
proteins control the biophysical properties of AMPA receptors.
Thus the discovery of stargazin has opened a new chapter in the
molecular regulation of AMPA receptors and by implication,
learning and memory.
Could you summarize the significance of your paper in layman’s
terms?
Brain function depends upon neurons communicating with one
another via specialized contacts termed synapses. Most synapses
release glutamate that activates AMPA receptors on the
postsynaptic neuron. It is well accepted that learning and memory
involves long lasting increases in the strength of synaptic
transmission and this increase is due, in large part, to the
recruitment of AMPA receptors to the synapse. Our paper
demonstrated that a novel protein, stargazin, plays a critical
role in this trafficking of AMPA receptors. Thus the paper
provides a modest, but important, step toward understanding the
molecular basis of learning and memory.
How did you become involved in this research and were there
successes or failures?
I have long been fascinated by the cellular and molecular basis
of learning and memory. Prior to this paper, work in my lab, as
well as in others, had established that synaptic plasticity, which
underlies certain forms of learning and memory, involves the rapid
trafficking of the AMPA-type glutamate receptor at synapses. This
realization stimulated great interest in determining the molecular
basis for AMPA receptor trafficking. Most studies involved
isolating synaptic proteins and determining how these proteins
interact with AMPA receptors. For our studies we took advantage of
a spontaneous mutant mouse with ataxia and epilepsy. This mouse
has a mutation in a small membrane protein termed stargazin and as
a result lacks functional AMPA receptors in cerebellar granule
cells. Our paper showed how stargazin regulates AMPA receptors in
the cerebellum and elsewhere in the brain.
What are the social or political implications of your
research?
With an aging society, cognitive impairment from diseases, such
as Alzheimer’s, is fast
becoming a leading health problem. It is hoped that by elucidating
the cellular and molecular basis of learning and memory a rational
pharmacology will emerge for the treatment of cognitive decline.
Roger A. Nicoll, M.D.
Professor
Department of Cellular and Molecular Pharmacology
University of California
San Francisco, CA, USA
|
Return to Fast Moving Fronts |
Return to Special Topics main menu
|